Epilepsy and Ejection fraction decreased
Summary:
Ejection fraction decreased is found among people with Epilepsy, especially for people who are 60+ old.
The study analyzes which people have Ejection fraction decreased with Epilepsy. It is created by eHealthMe based on reports of 20 people who have Epilepsy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Epilepsy?
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures) is found to be associated with 1,164 drugs and 1,778 conditions by eHealthMe. Check the latest studies of Epilepsy.
What is Ejection fraction decreased?
Ejection fraction decreased (systolic heart failure) is found to be associated with 1,062 drugs and 1,256 conditions by eHealthMe. Check the latest studies of Ejection fraction decreased.
20 people who have Epilepsy and Ejection Fraction Decreased are studied.

Age of people who have Epilepsy and experienced Ejection Fraction Decreased *:
- 0-1: 0.0 %
- 2-9: 10.53 %
- 10-19: 5.26 %
- 20-29: 5.26 %
- 30-39: 26.32 %
- 40-49: 0.0 %
- 50-59: 5.26 %
- 60+: 47.37 %
Common co-existing conditions for these people *:
- Gastric Cancer (stomach cancer): 5 people, 25.00%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 20.00%
- Suicide Attempt: 3 people, 15.00%
- High Blood Cholesterol: 2 people, 10.00%
- Depression: 2 people, 10.00%
- Myoclonic Epilepsy (type of epilepsy with quick little jerks of the arms, shoulder, or occasionally the legs): 2 people, 10.00%
- Gout (uric acid crystals building up in the body): 2 people, 10.00%
- Toothaches (tooth pain): 1 person, 5.00%
- Astrocytoma (tumour of the brain that originate in a particular kind of glial-cells): 1 person, 5.00%
- Cardiomyopathy (weakening of the heart muscle): 1 person, 5.00%
Common drugs taken by these people *:
- Perampanel: 3 people, 15.00%
- Depakene: 3 people, 15.00%
- Clobazam: 3 people, 15.00%
- Lapatinib: 3 people, 15.00%
- Capecitabine: 3 people, 15.00%
- Keppra: 3 people, 15.00%
- Tylenol: 3 people, 15.00%
- Duricef: 2 people, 10.00%
- Crestor: 2 people, 10.00%
- Coreg: 2 people, 10.00%
Common symptoms for these people *:
- Pneumonia: 10 people, 50.00%
- Fever: 9 people, 45.00%
- Nausea And Vomiting: 6 people, 30.00%
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 6 people, 30.00%
- Productive Cough: 5 people, 25.00%
- Pulmonary Infarction (death of a small area of lung): 5 people, 25.00%
- Fatigue (feeling of tiredness): 5 people, 25.00%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 25.00%
- Oedema Peripheral (superficial swelling): 5 people, 25.00%
- Pulmonary Embolism (blockage of the main artery of the lung): 5 people, 25.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Ejection fraction decreased?
- Check whether Ejection fraction decreased is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Epilepsy (129,285 reports)
- Ejection fraction decreased (19,545 reports)
All the drugs that are associated with Ejection fraction decreased:
- Ejection fraction decreased (1,062 drugs)
All the conditions that are associated with Ejection fraction decreased:
- Ejection fraction decreased (1,256 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Ejection fraction decreased and Epilepsy, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Verapamil Hydrochloride and Atenolol - 9 seconds ago
- Drug interactions of Movantik and Hctz - 9 seconds ago
- Centrum and Sleep Apnoea Syndrome for Women aged 50-59 - 10 seconds ago
- Centrum and Sleep Apnea Syndrome for Women aged 50-59 - 11 seconds ago
- Epinephrine and Uveitis for Women aged 60+ - 12 seconds ago
- Epinephrine and Posterior Uveitis for Women aged 60+ - 12 seconds ago
- Epinephrine and Pars Planitis for Women aged 60+ - 12 seconds ago
- Epinephrine and Choroiditis for Women aged 60+ - 12 seconds ago
- Epinephrine and Chorioretinitis for Women aged 60+ - 13 seconds ago
- Epinephrine and Anterior Uveitis for Women aged 60+ - 13 seconds ago